T&L Co Ltd (340570) Stock Price & News

340570:KOSDAQ

T&L Co Ltd

₩23,850.00

+1.92%

(+450.00) 1D

Nov 10, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 340570...

Open

₩23,700

High

₩24,500

Low

₩23,700

Mkt. cap

383.27B

Avg. vol.

52.14K

Volume

30.53K

Dividend

3.14%

Quarterly dividend

₩187

Ex-dividend date

Dec 27, 2024

P/E ratio

7.54

52-wk high

₩35,800

52-wk low

₩21,550

EPS

₩3,162

Shares outstanding

16.07M

No. of employees

250

Open

₩23,700

High

₩24,500

Low

₩23,700

Mkt. cap

383.27B

Avg. vol.

52.14K

Volume

30.53K

Dividend

3.14%

Quarterly dividend

₩187

Ex-dividend date

Dec 27, 2024

P/E ratio

7.54

52-wk high

₩35,800

52-wk low

₩21,550

EPS

₩3,162

Shares outstanding

16.07M

No. of employees

250

Related stocks

PharmaResearch Co Ltd

Value Added Technology Co Ltd

₩16,980.00

+1.56%

News stories

From web sources and news partners

Investing.com

1 hour ago

S&P 500 futures fall sharply after October inflation data By Reuters

Invezz

34 minutes ago

Dow falls 122 points as US stocks slide on inflation and Fed rate fears

JournalArta

39 minutes ago

Stock Market Today: S&P 500 Slips 0.49% and Nasdaq 0.61% at the Open as 10-Year Yield Climbs to 4.96%

CNBC

2 hours ago

S&P 500 futures rise as traders brace for crucial consumer inflation report

About T&L Co Ltd

CEOYoon-so Choi

Employees250

Founded1998

Headquarters-

SectorHealth Care

IndustryMedical device

Websitetnl.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	40.67B	33.40B	45.07B	56.02B
Cost of goods sold	22.03B	20.80B	22.51B	26.10B
Cost of revenue	22.03B	20.80B	22.51B	26.10B
Research and development expenses	935.54M	2.12B	767.10M	852.46M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.12B	5.98B	3.07B	3.61B
Operating expense	6.51B	8.58B	4.29B	4.96B
Total operating expenses	28.53B	29.38B	26.80B	31.06B
Operating income	12.14B	4.02B	18.27B	24.96B
Other non operating income	156.77M	-149.57M	-55.85M	64.37M
EBT including unusual items	14.27B	3.73B	20.65B	26.54B
EBT excluding unusual items	14.13B	4.80B	20.65B	26.49B
Income tax expense	2.94B	675.00M	4.21B	6.59B
Effective tax rate	20.59%	18.09%	20.40%	24.83%
Other operating expenses	54.38M	60.40M	11.96M	8.77M
Net income	11.33B	3.06B	16.44B	19.95B
Net profit margin	27.86%	9.15%	36.48%	35.61%
Earnings per share	-	-	-	-
Interest and investment income	625.37M	267.60M	484.89M	600.55M
Interest expense	-2.74M	-3.34M	-2.35M	-828.36K
Net interest expenses	622.62M	264.25M	482.53M	599.72M
Depreciation and amortization charges	401.48M	398.07M	418.33M	482.84M
EBITDA	13.31B	5.23B	19.46B	26.23B
Gain or loss from assets sale	405.00K	93.78M	1.00K	-43.93M

Finance

Ask anything